Prudential Financial’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9K | Buy |
+14,980
| New | +$10.9K | ﹤0.01% | 2420 |
|
|
2023
Q3 | – | Sell |
-82,529
| Closed | -$352K | – | 2609 |
|
|
2023
Q2 | $352K | Buy |
82,529
+19,642
| +31% | +$83.9K | ﹤0.01% | 2246 |
|
|
2023
Q1 | $430K | Sell |
62,887
-2,800
| -4% | -$19.2K | ﹤0.01% | 2140 |
|
|
2022
Q4 | $520K | Buy |
65,687
+55
| +0.1% | +$436 | ﹤0.01% | 2005 |
|
|
2022
Q3 | $631K | Sell |
65,632
-500
| -0.8% | -$4.81K | ﹤0.01% | 1966 |
|
|
2022
Q2 | $479K | Sell |
66,132
-560
| -0.8% | -$4.06K | ﹤0.01% | 2156 |
|
|
2022
Q1 | $861K | Sell |
66,692
-1,823
| -3% | -$23.5K | ﹤0.01% | 1941 |
|
|
2021
Q4 | $1.21M | Sell |
68,515
-1,369
| -2% | -$24.2K | ﹤0.01% | 1792 |
|
|
2021
Q3 | $1.23M | Sell |
69,884
-4,258
| -6% | -$74.8K | ﹤0.01% | 1697 |
|
|
2021
Q2 | $1.03M | Sell |
74,142
-74,804
| -50% | -$1.03M | ﹤0.01% | 1823 |
|
|
2021
Q1 | $2.18M | Sell |
148,946
-102,510
| -41% | -$1.5M | ﹤0.01% | 1420 |
|
|
2020
Q4 | $4.37M | Buy |
251,456
+41,764
| +20% | +$726K | 0.01% | 1063 |
|
|
2020
Q3 | $3.85M | Buy |
209,692
+135,786
| +184% | +$2.49M | 0.01% | 1023 |
|
|
2020
Q2 | $1.32M | Buy |
+73,906
| New | +$1.32M | ﹤0.01% | 1518 |
|